The Global Minimally Invasive Spine Technologies Market Size is valued at 3.63 billion in 2023 and is predicted to reach 8.17 billion by the year 2031 at a 10.75% CAGR during the forecast period for 2024-2031.
In recent decades, there has been a significant interest in minimally invasive spine surgery (MISS). This trend has been primarily driven by its fundamental principle of reducing approach-related trauma while performing comparable outcomes to conventional open spine procedures. Due to advancements in technology and technical knowledge.
Minimally Invasive Spine Surgery (MISS) is no longer limited to treating simple spinal stenosis but can now effectively address complex spinal pathologies, inclusive of metastasis, trauma, and adult spinal deformity. Minimally Invasive Spine Technologies are produced using plant or animal waste and thus are eco-friendly, non-toxic, and abundant in nature. Hence, the adoption of Minimally Invasive is rapidly growing in current times.
The international market for minimally invasive spinal surgery has been dramatically influenced by the COVID-19 pandemic. The interruption and termination of surgical services as well as the consequences of the illness for public health, also have a collateral effect. For instance, a research study titled "COVID-19 Pandemic and Elective Spinal Surgery Cancellations" that was released in December 2021 claimed that the COVID-19 pandemic led to the suspension of elective procedures because resources were reallocated to the care of COVID-19 patients. Following the start of elective surgeries, many patients delayed surgery, and many are still waiting for a new appointment. This could have prolonged their discomfort and functional impairment. It is projected that situations like this will reduce the need for spinal surgical equipment due to the pandemic.
The major factors that are expected to expedite the growth of the market over the anticipated period include technological advancements in surgical equipment and rising demand for minimally invasive surgeries, an increase in the incidence of spinal disorders, the rising popularity of physician-owned ambulatory surgical centers, and an increase in the geriatric and obese population.
The Minimally Invasive Spine Technologies market is segmented on the basis of condition and end user. Based on the condition, the market is segmented as Herniated Disc, Spinal Stenosis, Degenerative Disc Disease, Spinal Deformity, Spinal Fracture, Spinal Infection, and Spinal Tumor. The end user segment includes Hospitals, Ambulatory Surgery Centers, and Orthopedic Clinics.
The hospital segment covered the largest revenue share. On the other hand, ambulatory surgery centres are expected to undergo the fastest growth rate during the anticipated period. The United States currently has over 5,500 ambulatory surgery centers certified by Medicare. Compared to hospitals, ambulatory surgical centers provide patients with surgery at reduced costs and with more schedule freedom. These healthcare institutions, sometimes known as same-day surgery centers, release patients following minor surgeries.
The orthopedic market share was ranked second overall. No muscles need to be cut or severed during orthopedic MIS operations. As a result, this strategy has enhanced patient satisfaction and accelerated the healing process. MIS is most frequently used during knee and hip replacement surgeries. Surgery that has fewer operational, postoperative, and hospitalization-related problems is sought after by hospitals and doctors. Pats, on the other hand, look for surgical procedures that lessen trauma and enable quick recovery.
Growing geriatric population and a high prevalence of unintentional injuries made North America the market leader in the regional MIS industry. The US spends more on healthcare per person than any other nation in the world, as per a report by the Organisation for Economic Co-operation and Development (OECD). Additionally, patients in the US have a choice over the providers and modes of treatment. The MIS market in North America is anticipated to benefit from this. On the other hand, from 2024 to 2031, the Asia Pacific area is expected to experience the fastest growth.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 3.63 Bn |
| Revenue forecast in 2031 | USD 8.17 Bn |
| Growth rate CAGR | CAGR of 10.75% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Condition, End-user |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | AMS Group, Alphatec Holdings, Inc., Aurora Spine, Inc., B. Braun SE, Boston Scientific Corporation, Globus Medical, Inc., Johnson & Johnson, Medtronic plc, NuVasive, Inc., ORTHOFIX MEDICAL INC., Precision Spine, Inc., Richard Wolf GmbH, Spineart, Spineology Inc., and Stryker Corporation. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Minimally Invasive Spine Technologies Market By Condition-
Minimally Invasive Spine Technologies Market By End User-
Minimally Invasive Spine Technologies Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.